[Antidotes for the new oral anticoagulants: Reality and expectations]

Med Clin (Barc). 2016 Jun 3;146(11):488-90. doi: 10.1016/j.medcli.2015.11.014. Epub 2016 Jan 6.
[Article in Spanish]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Administration, Oral
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Anticoagulants / adverse effects*
  • Arginine / analogs & derivatives*
  • Arginine / therapeutic use
  • Coagulants / therapeutic use*
  • Factor Xa / therapeutic use*
  • Hemorrhage / chemically induced*
  • Hemorrhage / drug therapy*
  • Humans
  • Piperazines / therapeutic use*
  • Recombinant Proteins / therapeutic use*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Anticoagulants
  • Coagulants
  • PRT064445
  • Piperazines
  • Recombinant Proteins
  • Arginine
  • idarucizumab
  • Factor Xa
  • PER977